Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F, American Association of Oral and Maxillofacial Surgeons (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw–2014 update. J Oral Maxillofac Surg Am Assoc Oral Maxillofac Surg 72:1938–1956. https://doi.org/10.1016/j.joms.2014.04.031

Article  Google Scholar 

Yarom N, Shapiro CL, Peterson DE, Van Poznak CH, Bohlke K, Ruggiero SL, Migliorati CA, Khan A, Morrison A, Anderson H, Murphy BA, Alston-Johnson D, Mendes RA, Beadle BM, Jensen SB, Saunders DP (2019) Medication-related osteonecrosis of the jaw: MASCC/ISOO/ASCO clinical practice guideline. J Clin Oncol 37:2270–2290. https://doi.org/10.1200/JCO.19.01186

Article  PubMed  Google Scholar 

Japanese Allied Committee on Osteonecrosis of the Jaw, Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, Taguchi A, Nagata T, Urade M, Shibahara T, Toyosawa S (2017) Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. J Bone Miner Metab 35:6–19. https://doi.org/10.1007/s00774-016-0810-7

Article  CAS  Google Scholar 

Hayashida S, Soutome S, Yanamoto S, Fujita S, Hasegawa T, Komori T, Kojima Y, Miyamoto H, Shibuya Y, Ueda N, Kirita T, Nakahara H, Shinohara M, Umeda M (2017) Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysis. J Bone Miner Res 32:2022–2029. https://doi.org/10.1002/jbmr.3191

Article  CAS  PubMed  Google Scholar 

Graziani F, Vescovi P, Campisi G, Favia G, Gabriele M, Gaeta GM, Gennai S, Goia F, Miccoli M, Peluso F, Scoletta M, Solazzo L, Colella G (2012) Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: a retrospective survey of 347 cases. J Oral Maxillofac Surg 70:2501–2507. https://doi.org/10.1016/j.joms.2012.05.019

Article  PubMed  Google Scholar 

Ruggiero SL, Kohn N (2015) Disease stage and mode of therapy are important determinants of treatment outcomes for medication related osteonecrosis of the jaw. J Oral Maxillofac Surg 73:S94–S100. https://doi.org/10.1016/j.joms.2015.09.024

Article  PubMed  Google Scholar 

Kim HY, Lee SJ, Kim SM, Myoung H, Hwang SJ, Choi JY, Lee JH, Choung PH, Kim MJ, Seo BM (2017) Extensive surgical procedures result in better treatment outcomes for bisphosphonate-related osteonecrosis of the jaw in patients with osteoporosis. J Oral Maxillofac Surg 75:1404–1413. https://doi.org/10.1016/j.joms.2016.12.014

Article  PubMed  Google Scholar 

Mücke T, Koschinski J, Deppe H, Wagenpfeil S, Pautke C, Mitchell DA, Wolff KD, Hölzle F (2011) Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws. J Cancer Res Clin Oncol 137:907–913. https://doi.org/10.1007/s00432-010-0953-1

Article  CAS  PubMed  Google Scholar 

Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) American Association of Oral and Maxillofacial Surgeons’ position paper on medication-related osteonecrosis of the Jaws-2022 update. J Oral Maxillofac Surg 80:920–943. https://doi.org/10.1016/j.joms.2022.02.008

Article  PubMed  Google Scholar 

Suei Y (2013) Radiographic findings of bisphosphonate-related osteomyelitis of the jaw: investigation of the diagnostic points by comparison with radiation osteomyelitis, suppurative osteomyelitis, and diffuse sclerosing osteomyelitis. Oral Radiol 29:121–134

Article  Google Scholar 

Kojima Y, Kawaoka Y, Sawada S, Hayashida S, Okuyama K, Yutori H, Kawakita A, Ishida S, Soutome S, Yanamoto S, Umeda M, Iwai H (2019) Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw. J Bone Miner Metab 37:913–919. https://doi.org/10.1007/s00774-019-00994-1

Article  PubMed  Google Scholar 

Kojima Y, Soutome S, Otsuru M, Hayashida S, Sakamoto Y, Sawada S, Umeda M (2022) Factors exacerbating clinical symptoms and CT findings in patients with medication-related osteonecrosis of the jaw receiving conservative therapy: a multicenter retrospective study of 53 cases. Int J Environ Res Public Health 19:7854. https://doi.org/10.3390/ijerph19137854

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soutome S, Yanamoto S, Sumi M, Hayashida S, Kojima Y, Sawada S, Rokutanda S, Iwai H, Saito T, Umeda M (2021) Effect of periosteal reaction in medication-related osteonecrosis of the jaw on treatment outcome after surgery. J Bone Miner Metab 39:302–310. https://doi.org/10.1007/s00774-020-01154-6

Article  PubMed  Google Scholar 

Soutome S, Otsuru M, Hayashida S, Yanamoto S, Sasaki M, Takagi Y, Sumi M, Kojima Y, Sawada S, Iwai H, Umeda M, Saito T (2021) Periosteal reaction of medication-related osteonecrosis of the jaw (MRONJ): clinical significance and changes during conservative therapy. Support Care Cancer 29:6361–6368. https://doi.org/10.1007/s00520-021-06214-9

Article  PubMed  Google Scholar 

Rupel K, Ottaviani G, Gobbo M, Contardo L, Tirelli G, Vescovi P, Di Lenarda R, Biasotto M (2014) A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncol 50:1049–1057. https://doi.org/10.1016/j.oraloncology.2014.08.016

Article  CAS  PubMed  Google Scholar 

Fliefel R, Tröltzsch M, Kühnisch J, Ehrenfeld M, Otto S (2015) Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Maxillofac Surg 44:568–585. https://doi.org/10.1016/j.ijom.2015.01.026

Article  CAS  PubMed  Google Scholar 

Bisdas S, Chambron Pinho N, Smolarz A, Sader R, Vogl TJ, Mack MG (2008) Bisphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients. Clin Radiol 63:71–77. https://doi.org/10.1016/j.crad.2007.04.023

Article  CAS  PubMed  Google Scholar 

Wongratwanich P, Shimabukuro K, Konishi M, Nagasaki T, Ohtsuka M, Suei Y, Nakamoto T, Verdonschot RG, Kanesaki T, Sutthiprapaporn P, Kakimoto N (2021) Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review. Dentomaxillofac Radiol 50:20200417. https://doi.org/10.1259/dmfr.20200417

Article  PubMed  PubMed Central  Google Scholar 

Lipton A, Fizazi K, Stopeck AT, Henry DH, Brown JE, Yardley DA, Richardson GE, Siena S, Maroto P, Clemens M, Bilynskyy B, Charu V, Beuzeboc P, Rader M, Viniegra M, Saad F, Ke C, Braun A, Jun S (2012) Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials. Eur J Cancer 48:3082–3092. https://doi.org/10.1016/j.ejca.2012.08.002

Article  CAS  PubMed  Google Scholar 

Weinstein RS, Roberson PK, Manolagas SC (2009) Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med 360:53–62. https://doi.org/10.1056/NEJMoa0802633

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kopper L (2012) Denosumab–a powerful RANKL inhibitor to stop lytic metastases and other bone loss actions by osteoclasts. Pathol Oncol Res 18:743–747. https://doi.org/10.1007/s12253-012-9538-4

Article  CAS  PubMed  Google Scholar 

Baba A, Ojiri H, Goto TK, Ikeda K, Yamauchi H, Ogino N, Mogami T (2019) CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication), Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4). Jpn Dent Sci Rev 55:58–64

Article  PubMed  PubMed Central  Google Scholar 

Moridera K, Kitajima K, Yoshikawa K, Takaoka K, Tsuchitani T, Noguchi K, Kishimoto H, Yamakado K (2022) Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings. Jpn J Radiol 40:492–499. https://doi.org/10.1007/s11604-021-01226-1

Article  PubMed  Google Scholar 

Soutome S, Otsuru M, Hayashida S, Murata M, Yanamoto S, Sawada S, Kojima Y, Funahara M, Iwai H, Umeda M, Saito T (2021) Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients. Sci Rep 11:17226. https://doi.org/10.1038/s41598-021-96480-8

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Soutome S, Otsuru M, Murata M, Morishita K, Omori K, Suyama K, Hayashida S, Umeda M, Saito T (2022) Risk factors for developing medication-related osteonecrosis of the jaw when preserving the tooth that can be a source of infection in cancer patients receiving high-dose antiresorptive agents: a retrospective study. Support Care Cancer 30:7241–7248. https://doi.org/10.1007/s00520-022-07134-y

Article  PubMed  Google Scholar